Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for instructions and the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2020 | (b) 2021 | (c) 2022 | (d) 2023 | (e) 2024 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | 1,017,110 | 1,633,232 | 1,293,738 | 1,304,241 | 2,047,778 | 7,296,099 |
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf .... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | 1,017,110 | 1,633,232 | 1,293,738 | 1,304,241 | 2,047,778 | 7,296,099 |
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f) .. | 2,615,960 | |||||
| 6 | Public support. Subtract line 5 from line 4. | 4,680,139 | |||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2020 | (b) 2021 | (c) 2022 | (d) 2023 | (e) 2024 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | 1,017,110 | 1,633,232 | 1,293,738 | 1,304,241 | 2,047,778 | 7,296,099 |
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | 20,513 | 137 | 7,492 | 30,853 | 32,082 | 91,077 |
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | ||||||
| 11 | Total support. Add lines 7 through 10 | 7,387,176 | |||||
Calendar year (or fiscal
year beginning in) ![]() |
(a) 2020 | (b) 2021 | (c) 2022 | (d) 2023 | (e) 2024 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | ||||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | ||||||
| 6 | Total. Add lines 1 through 5 | ||||||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | ||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2020 | (b) 2021 | (c) 2022 | (d) 2023 | (e) 2024 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | ||||||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | ||||||
| 11 | Net income from unrelated business activities not included on line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | ||||||
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by 0.035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | 1 | |
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
2 | |
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | 3 | |
| 4 Amounts paid to acquire exempt-use assets | 4 | |
| 5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI) | 5 | |
| 6 Other distributions (describe in Part VI). See instructions | 6 | |
| 7Total annual distributions. Add lines 1 through 6. | 7 | |
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
8 | |
| 9 Distributable amount for 2024 from Section C, line 6 | 9 | |
| 10 Line 8 amount divided by Line 9 amount | 10 | |
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2024 |
(iii) Distributable Amount for 2024 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2024 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2024 (reasonable cause required-- explain in Part VI).
See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2024: | ||||
| a From 2019....... | ||||
| b From 2020....... | ||||
| c From 2021....... | ||||
| d From 2022....... | ||||
| e From 2023....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2024 distributable amount | ||||
|
i
Carryover from 2019 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from line 3f. | ||||
| 4Distributions for 2024 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2024 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from line 4. | ||||
|
5
Remaining underdistributions for years prior to 2024, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2024. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2025. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2020..... | ||||
| b Excess from 2021..... | ||||
| c Excess from 2022..... | ||||
| d Excess from 2023..... | ||||
| e Excess from 2024..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | |
| Software Version: |
| Return Reference | Explanation |
|---|---|
| FORM 990, PART III, LINE 2 | THE KANSAS CITY BIOSECURE MANUFACTURING TECH HUB (KC BIOHUB) SERVES AS A BACKBONE ORGANIZATION FOR THE REGION'S BIOLOGICS AND BIOMANUFACTURING CLUSTER, AND OUR ACTIVITIES ARE DESIGNED TO MEET THE NEEDS OF INDUSTRY, ENTREPRENEURS, AND OUR COMMUNITY. ONE OF 31 TECH HUBS DESIGNATED BY THE U.S. DEPARTMENT OF COMMERCE'S ECONOMIC DEVELOPMENT ADMINISTRATION (EDA), KC BIOHUB HAS BEEN ENDORSED BY THE FEDERAL GOVERNMENT AS AN ECOSYSTEM WITH THE POTENTIAL TO ACHIEVE GLOBAL INDUSTRY LEADERSHIP WITHIN TEN YEARS. |
| FORM 990, PART III, LINE 4A | 1. ADVANCING THE KC REGION'S LIFE SCIENCES ECOSYSTEM: "PATH TO 2025" NEARLY A DECADE AGO, BIONEXUS KC COLLABORATED WITH STAKEHOLDERS, DELOITTE, AND THE COMMUNITY TO DEVELOP A 10-YEAR STRATEGIC PLAN CALLED THE PATH TO 2025, IDENTIFYING KEY LIFE SCIENCES OPPORTUNITIES AND FOUNDATIONAL ELEMENTS NECESSARY FOR REGIONAL GROWTH. THE PATH TO 2025, STILL RELEVANT TODAY, GUIDES BIONEXUS KC AND THE REGION IN THE WORK WE COLLECTIVELY PRIORITIZE AND ADVANCE AND, IN 2024, BIONEXUS KC LED REGIONAL EFFORTS CONVENING STAKEHOLDERS AROUND KEY COLLABORATIVE OPPORTUNITIES. THE KC BIOHUB FOCUSED ON GROWING THE BIOMANUFACTURING CAPACITY OF LARGE MOLECULES AND BIOLOGICS THAT ARE VITAL TO ANIMAL HEALTH, CANCER RESEARCH AND TREATMENT, NEUROSCIENCE, RARE DISEASES, AUTOIMMUNE DISEASES, AND PREVENTION OF INFECTIOUS DISEASES. THIS INITIATIVE ELEVATED THE REGION AND BIONEXUS KC TO NATIONAL PROMINENCE, INCREASING GLOBAL AWARENESS OF THE AREA'S SCIENTIFIC CONTRIBUTIONS. AS A RESULT, BIONEXUS KC AND THE KC REGION HOSTED SEVERAL FEDERAL DELEGATIONS IN 2024, INCLUDING BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA), THE ECONOMIC DEVELOPMENT ADMINISTRATION (EDA), THE NATIONAL SECURITY COMMISSION ON EMERGING BIOTECHNOLOGY (NSCEB), AND SEVERAL CONGRESSIONAL DELEGATIONS TO FEATURE OUR REGIONAL ASSETS AND BUILD CONNECTED RELATIONSHIPS TO OUR STAKEHOLDERS. DIGITAL HEALTH KC MARKED A MAJOR MILESTONE ON THE PATH TO 2025. LONG IDENTIFIED AS A KEY REGIONAL STRENGTH AND OPPORTUNITY, DIGITAL HEALTH HAS BECOME ONE OF OUR AREA'S MOST ROBUST INDUSTRIES. THE ECOSYSTEM INCLUDES 125+ DIGITAL HEALTH COMPANIES AND CONNECTS INVESTORS, ENTREPRENEURS, HEALTHCARE LEADERS, AND COMMUNITY MEMBERS AROUND TECHNOLOGY-DRIVEN HEALTH IMPROVEMENT EFFORTS. COLLABORATION CONTINUES TO TIE ALL OUR WORK TOGETHER. WE ADVANCED CAPITAL: BRINGING MORE INVESTORS TO THE TABLE, EDUCATING INVESTORS ON LIFE SCIENCES OPPORTUNITIES, AND HELPING ENTREPRENEURS NAVIGATE ANGEL AND VENTURE FUNDING PROCESSES. TO ADDRESS THE TALENT NEEDS OF THE REGION, WE LAUNCHED THE BIOTECH FOR MO TRAINING PROGRAM IN PARTNERSHIP WITH FULL EMPLOYMENT COUNCIL AND METROPOLITAN COMMUNITY COLLEGE. THROUGH COLLECTIVE EFFORTS, BIONEXUS KC AND THE REGION WILL FILL IN THE GAPS IN THE LIFE SCIENCES ECOSYSTEM, DRIVE SIGNIFICANT GROWTH, AND SHARE THE STORY OF A THRIVING ECOSYSTEM. 2. DIGITAL HEALTH KC AND DIGITAL HEALTH DAY IN 2024, DIGITAL HEALTH KC MADE CONSIDERABLE STRIDES IN OUR MISSION OF SUPPORTING EARLY-STAGE DIGITAL HEALTH COMPANIES AND FOSTERING INNOVATION IN THE KANSAS CITY REGION. AT THE CENTER OF HEALTH + DATA, DIGITAL HEALTH KC IS ADVANCING THE REGION'S DIGITAL HEALTH CLUSTER THROUGH MEANINGFUL COLLABORATIONS AND STRATEGIC PARTNERSHIPS. MORE THAN JUST AN ORGANIZATION, DIGITAL HEALTH KC REPRESENTS A COMMUNITY-POWERED INITIATIVE THAT UNITES CRUCIAL PARTNERS INCLUDING THE UNIVERSITY OF MISSOURI-KANSAS CITY INNOVATION CENTER, KC DIGITAL DRIVE, AND PIPELINE ENTREPRENEURS TO NURTURE AND ELEVATE LOCAL TALENT. DIGITAL HEALTH KC HAS SERVED AS A POWERFUL CATALYST FOR INNOVATION, TRANSFORMING PREVIOUSLY DISCONNECTED COMPANIES INTO A COHESIVE ECOSYSTEM OF INNOVATORS ALIGNED TOWARD ECONOMIC GROWTH. OUR COMMUNITY ENGAGEMENT EFFORTS HAVE BEEN SIGNIFICANT, CREATING INTENTIONAL CONNECTIONS THAT SPARK COLLABORATION. NETWORKING EVENTS PROVIDE OPPORTUNITIES TO CELEBRATE WINS, SHARE FUTURE PLANS, AND BUILD REGIONAL CONNECTIONS, WHILE HEALTHCARE 201 SESSIONS OFFER EXPERT-LED EDUCATION ON RELEVANT DIGITAL HEALTH TOPICS. THROUGH THESE INITIATIVES, DIGITAL HEALTH KC HAS ESTABLISHED MEANINGFUL RELATIONSHIPS WITH STARTUPS, INVESTORS, DIGITAL HEALTH COMPANIES, AND INDUSTRY PARTNERS. THESE GATHERINGS HAVE FOSTERED NEW PARTNERSHIPS AND HAVE ACCELERATED KNOWLEDGE SHARING ACROSS THE DIGITAL HEALTH COMMUNITY IN KANSAS CITY. THE IMPACT OF DIGITAL HEALTH KC EXTENDS BEYOND NETWORKING, AS WE'VE SUCCESSFULLY CONNECTED EARLY-STAGE COMPANIES WITH FUNDING OPPORTUNITIES, PROVIDED PERSONALIZED GUIDANCE ON BUSINESS STRATEGIES AND PRODUCT-MARKET FIT, AND FACILITATED VALUABLE PARTNERSHIPS BETWEEN FOUNDERS. WE HAVE SUPPORTED ENTREPRENEURS IN AMPLIFYING THEIR STORIES, INCLUDING CHRIS JONES, FOUNDER AND CEO OF MATCHRITECARE, WHO SHARED THEIR JOURNEY ON THE NATIONALLY STREAMED PROGRAM, ADVANCEMENTS WITH TED DANSON. THE CULMINATION OF THE YEAR'S EXCITING AND TRANSFORMATIVE WORK WAS CELEBRATED AT OUR INAUGURAL ANNUAL EVENT, DIGITAL HEALTH DAY. THIS LANDMARK GATHERING ORGANIZED 15 INDUSTRY EXPERT SPEAKERS AND 400+ LEADERS TO NETWORK, COLLABORATE, AND CELEBRATE ACHIEVEMENTS IN OUR REGION'S DIGITAL HEALTH EFFORTS. A HIGHLIGHT OF THE DAY WAS THE LUMI AWARDS CEREMONY, RECOGNIZING INDIVIDUALS ILLUMINATING THE PATH FORWARD IN DIGITAL HEALTH INNOVATION. THE AWARDS CELEBRATED DIVERSE CONTRIBUTIONS ACROSS OUR ECOSYSTEM. 3. KC BIOHUB THE KANSAS CITY BIOSECURE MANUFACTURING TECH HUB (KC BIOHUB) SERVES AS A BACKBONE ORGANIZATION FOR THE REGION'S BIOLOGICS AND BIOMANUFACTURING CLUSTER, AND OUR ACTIVITIES ARE DESIGNED TO MEET THE NEEDS OF INDUSTRY, ENTREPRENEURS, AND OUR COMMUNITY. ONE OF 31 TECH HUBS DESIGNATED BY THE U.S. DEPARTMENT OF COMMERCE'S ECONOMIC DEVELOPMENT ADMINISTRATION (EDA), KC BIOHUB HAS BEEN ENDORSED BY THE FEDERAL GOVERNMENT AS AN ECOSYSTEM WITH THE POTENTIAL TO ACHIEVE GLOBAL INDUSTRY LEADERSHIP WITHIN TEN YEARS. OUR WORK INCLUDES SHORT- AND LONG-TERM STRATEGIES, LIKE: DRIVING INCREASED ACTIVITY TO KANSAS CITY'S EXISTING BIOMANUFACTURING CLUSTER THROUGH BOTH INCREASED ACTIVITY TO OUR EXISTING CRO/CDMO ASSETS AND SUPPORTING BIOMANUFACTURING SITE SELECTION ACTIVITY; DESIGNING A WORKFORCE DEVELOPMENT PIPELINE PREPARED TO TRAIN 10,000 WORKERS FOR "GOOD JOBS", FACILITATE SKILLS-BASED HIRING, AND MEET INDUSTRY AND WORKER NEEDS; DEVELOPING THE PHYSICAL INFRASTRUCTURE AND CAPITAL ASSETS THAT ENTREPRENEURS NEED TO SUCCESSFULLY GROW THEIR BUSINESSES AND BRING NEW LIFE-SAVING AND LIFE-IMPROVING INNOVATIONS TO MARKET; CREATING OPPORTUNITIES FOR SMALL BUSINESSES AND STARTUPS TO ENTER THIS MARKET BY HELPING THEM IDENTIFY NEW BUSINESS OPPORTUNITIES AND GAIN THE SPECIALIZED SKILLS AND KNOWLEDGE NEEDED TO OPERATE IN THIS HIGHLY REGULATED INDUSTRY; ENGAGING WITH THE COMMUNITY STRATEGICALLY AND AUTHENTICALLY FROM THE EARLIEST STAGE OF DEVELOPMENT TO BUILD LONG-TERM TRUST AND STRUCTURING INVESTMENTS SO THAT GROWTH IN THE INDUSTRY BENEFITS, RATHER THAN DISPLACES, DISINVESTED COMMUNITIES. THE GLOBAL PHARMA MARKET'S SHIFT FROM SMALL MOLECULES TO BIOLOGIC DRUGS OPENS NEW AVENUES TO BUILD U.S. COMPETITIVENESS IN BIOLOGICS PRODUCTION AS THE INDUSTRY UNDERGOES CHANGE. THE KC REGION HAS THE ASSETS TO LEAD IN THIS TRANSITION, LEVERAGING STRENGTHS IN ANIMAL AND HUMAN BIOLOGICS DEVELOPMENT AND MANUFACTURING AND EXPERTISE IN BIOSECURITY & BIODEFENSE. REGIONAL ASSETS INCLUDE FOUR R1 RESEARCH INSTITUTIONS, AS WELL AS PUBLIC AND NON-PROFIT ORGANIZATIONS LIKE THE NATIONAL BIO AND AGRO-DEFENSE FACILITY, MRIGLOBAL, MISSOURI UNIVERSITY RESEARCH REACTOR, CHILDREN'S MERCY RESEARCH INSTITUTE, AND THE UNIVERSITY OF KANSAS CANCER CENTER. THE PRIVATE SECTOR ALSO HAS A CRITICAL MASS OF BIOLOGICS MANUFACTURING AND ONE OF THE HIGHEST CONCENTRATED CLUSTERS OF CONTRACT RESEARCH, DEVELOPMENT, AND MANUFACTURING ORGANIZATIONS IN THE NATION. THIS INITIATIVE HAS BEEN UNDER DEVELOPMENT FOR FIVE YEARS, STEMMING FROM THE KC RISING "IDEAS" WORKING GROUP, CONVENING BUSINESS AND COMMUNITY LEADERS TO SELECT A CLUSTER FOR THE KC REGION TO TARGET TO INCREASE ECONOMIC GROWTH. THE KC BIOHUB TEAM, LED BY PRESIDENT MELISSA ROBERTS CHAPMAN, IS LEADING OUR REGION'S EFFORTS TO GROW A WORLD-LEADING BIOLOGICS AND BIOMANUFACTURING CLUSTER, WORKING WITH OUR CONSORTIUM MEMBERS TO DEVELOP A STRATEGIC PLAN, BUILD FOR OPERATIONAL SUSTAINABILITY, AND IMPLEMENT EARLY PROGRAMMATIC EFFORTS. |
| FORM 990, PART III, LINE 4A | 4. WORKFORCE DEVELOPMENT WITH THE RECENT DESIGNATION AS A U.S. TECH HUB, KANSAS CITY IS UNDERGOING A TRANSFORMATIONAL EXPANSION IN ITS BIOMANUFACTURING AND BIOTECHNOLOGY SECTOR. THE KC REGION HAS THE LARGEST CONCENTRATION OF ANIMAL HEALTH AND NUTRITION COMPANIES IN THE WORLD AND NOW AIMS TO STRENGTHEN THESE RESOURCES TO INCREASE DRUG DISCOVERY INNOVATION AND PRODUCTION OF BIOLOGICS FOR BOTH ANIMALS AND HUMANS. GROWTH OF THE BIOTECH SECTOR WILL CREATE A SURGING DEMAND FOR STABLE, HIGH-PAYING JOBS WITH UPWARD MOBILITY. THESE JOBS WILL REQUIRE DIVERSE LEVELS OF TECHNICAL SKILLS AND SCIENTIFIC KNOWLEDGE ACQUIRED THROUGH EITHER DEGREE PROGRAMS OR NON-DEGREE WORKFORCE TRAINING PROGRAMS. IN DIRECT RESPONSE TO THIS GROWING DEMAND, BIONEXUS KC AND KC BIOHUB ARE COORDINATING WITH REGIONAL BIOSCIENCE COMPANIES, RESEARCH INSTITUTIONS, AND PUBLIC WORKFORCE SYSTEMS TO FORMULATE STRATEGIC WORKFORCE DEVELOPMENT PROGRAMS THAT ARE BOTH INDUSTRY- RESPONSIVE AND ADAPTIVE TO COMMUNITY CHALLENGES. THE BIOSCIENCE INDUSTRY OCCUPATIONAL TRAINING AND EQUITY COLLABORATIVE HUB FOR MISSOURI (BIOTECH FOR MO) IS A STATEWIDE PROGRAM DELIVERING TRAINING FOR HIGH- DEMAND TECHNICAL SKILLS NECESSARY FOR LABORATORY TECHNICIAN ROLES THAT DO NOT REQUIRE A DEGREE. USING ALLOCATED ARPA FUNDS (MISSOURI DED WORKFORCE DEVELOPMENT TRAINING GRANT THROUGH BIOSTL), BIONEXUS KC SPEARHEADED THE DEVELOPMENT OF CAREER-LAUNCHING, SHORT-TERM TECHNICAL TRAINING COURSES TO BE DELIVERED IN KANSAS CITY. UNIQUE TO THESE COURSES IS AN EMBEDDED OPPORTUNITY FOR TRAINEES TO QUALIFY FOR INDUSTRY RECOGNIZED CREDENTIALS THROUGH THE BIOSCIENCE CORE SKILLS INSTITUTE, DEVELOP CAREER READINESS SKILLS THROUGH THE FULL EMPLOYMENT COUNCIL, AND GAIN FIRST-HAND EXPERIENCE OF TRAINING ON A COLLEGE CAMPUS AT METROPOLITAN COMMUNITY COLLEGE. ADDITIONALLY, INDUSTRY ACCESS TO TALENT WILL IMPROVE THROUGH DIRECT TRAINEE NETWORKING, HELPING COMPANIES FILL JOBS FASTER. 5. RESEARCH AND DEVELOPMENT GRANTS RESEARCH DEVELOPMENT GRANTS REPRESENT ONE OF BIONEXUS KC'S OLDEST AND MOST POPULAR PROGRAMS. GRANTS ARE AWARDED TO GENERATE PRELIMINARY DATA THAT SUPPORT SUBMISSION OF MAJOR MULTIDISCIPLINARY RESEARCH PROPOSALS TO GOVERNMENT OR PRIVATE FUNDING AGENCIES. APPLICANTS RECEIVE WRITTEN PEER REVIEWS, REGARDLESS OF WHETHER THEIR PROJECT RECEIVED FUNDING, TO HELP THEM IMPROVE FUTURE GRANT APPLICATIONS. THIS PROGRAM IS HIGHLY VALUED BY OUR STAKEHOLDERS. FROM 2002 TO 2024, THE BIONEXUS KC PROGRAM MANAGED 165 GRANTS THAT AWARDED OVER $10 MILLION IN RESEARCH FUNDING, SUPPORTING GROUNDBREAKING SCIENTIFIC INITIATIVES THROUGHOUT THE REGION. HISTORICALLY, FOR EVERY $1 INVESTED IN GRANTS, $13.10 HAS BEEN RETURNED TO THE REGION'S SCIENTISTS AND COMMUNITY IN EXTERNAL FUNDING. 6. SCIENCE2ART SCIENCE2ART TRANSFORMS COMPLEX RESEARCH INTO VISUALLY COMPELLING WORKS OF ART. THIS UNIQUE PROGRAM GIVES REGIONAL SCIENTISTS A PLATFORM TO SHARE THEIR DISCOVERIES THROUGH VISUAL STORYTELLING, MAKING THEIR WORK MORE ACCESSIBLE AND ENGAGING TO THE PUBLIC. EACH PIECE REPRESENTS A PERSONAL RESEARCH JOURNEY, CREATED IN COLLABORATION WITH THE SCIENTISTS AND THEIR TEAMS. PROCEEDS FROM THE AUCTIONED ARTWORK DIRECTLY SUPPORT STEAM EDUCATION INITIATIVES ACROSS OUR REGION. 7. BIONEXUS KC ANNUAL EVENT OUR 2024 BIONEXUS KC ANNUAL EVENT CELEBRATED HOMEGROWN INNOVATION AND THE COLLECTIVE IMPACT OF OUR REGION, BRINGING TOGETHER 500+ LEADERS, RESEARCHERS, STUDENTS, AND INNOVATORS AT THE MIDLAND. THIS YEAR'S EVENT HIGHLIGHTED OUR REGIONAL SUCCESS AND THE ROLE OFLOCALLY-DRIVEN INITIATIVES IN SHAPING THE FUTURE OF LIFE SCIENCES. THE KEYNOTE BY BRUCE KATZ, CO-FOUNDER AND INAUGURAL DIRECTOR OF THE NOWAK METRO FINANCE LAB, FOCUSED ON HOW CITIES AND REGIONS CAN HARNESS THEIR UNIQUE STRENGTHS TO DRIVE MEANINGFUL PROGRESS. KATZ HIGHLIGHTED THE SHIFTING POWER OF PLACE, EMPHASIZING HOW STRATEGIC LOCAL INVESTMENTS IN RESEARCH, ENTREPRENEURSHIP, AND INFRASTRUCTURE DRIVE INNOVATION AND LONG-TERM IMPACT. HE REINFORCED THE IMPORTANCE OF LEVERAGING KANSAS CITY'S EXPANDING LIFE SCIENCES ECOSYSTEM TO CREATE SUSTAINABLE GROWTH AND LASTING CHANGE. HIS INSIGHTS UNDERSCORED HOW COLLABORATION ACROSS SECTORS CAN AMPLIFY REGIONAL STRENGTHS AND ACCELERATE TRANSFORMATION. BEYOND THE KEYNOTE, THE EVENING PROVIDED AN OPPORTUNITY TO RECOGNIZE THE ACHIEVEMENTS AND PARTNERSHIPS THAT HAVE PROPELLED OUR REGION FORWARD. BIONEXUS KC HAS LONG BEEN A DRIVING FORCE BEHIND KANSAS CITY'S THRIVING LIFE SCIENCES COMMUNITY, CULTIVATING CONNECTIONS AND INNOVATION TO ADVANCE HEALTH AND SCIENTIFIC DISCOVERY. COLLABORATION IS OUR FOUNDATION AND BY WORKING TOGETHER ACROSS THE REGION WE ENSURE OUR REGION CONTINUES TO THRIVE AND PRODUCE ECONOMIC AND SOCIAL IMPACTS THAT BENEFIT ALL. THE ANNUAL EVENT SERVED AS BOTH A CELEBRATION OF PAST SUCCESSES AND A CALL TO ACTION FOR FUTURE COLLABORATION. WITH CONTINUED INVESTMENT IN LOCAL TALENT, RESEARCH, AND INNOVATION, OUR REGION IS POISED TO BECOME A NATIONAL LEADER IN LIFE SCIENCES. THE COMMITMENT AND PASSION OF OUR COMMUNITY WILL CONTINUE TO DRIVE GROUNDBREAKING DISCOVERIES, NEW MEDICAL TREATMENTS, AND TRANSFORMATIVE SOLUTIONS THAT IMPROVE LIVES. |
| FORM 990, PART III, LINE 4A | 8. KC ONE HEALTH DAY BIONEXUS KC, IN COLLABORATION WITH KU MEDICAL CENTER, KANSAS STATE UNIVERSITY OLATHE, AND KU EDWARDS, HOSTED KC ONE HEALTH DAY. THIS ANNUAL EVENT HIGHLIGHTS THE INTERCONNECTEDNESS OF HUMAN, ANIMAL, AND ENVIRONMENTAL HEALTH. THIS YEAR'S THEME, FOOD AS MEDICINE, EXPLORED THE CRITICAL ROLE OF NUTRITION IN OVERALL WELL-BEING, EMPHASIZING HOW FOOD PRODUCTION, ACCESSIBILITY, AND ENVIRONMENTAL FACTORS INFLUENCE HEALTH OUTCOMES. OVER 150 ATTENDEES GAINED VALUABLE INSIGHTS FROM EXPERTS IN HUMAN, ANIMAL, AND ENVIRONMENTAL HEALTH WHO SHARED INNOVATIVE RESEARCH APPROACHES TO IMPROVING HEALTH THROUGH NUTRITION. THEIR IN-DEPTH DISCUSSIONS CLEARLY UNDERSCORED THE CRITICAL IMPORTANCE OF CROSS-DISCIPLINARY COLLABORATION IN ADDRESSING HEALTH CHALLENGES THROUGH FOOD AND NUTRITION. THE EVENT ALSO PROVIDED AN OPPORTUNITY FOR STUDENTS TO SHOWCASE THEIR WORK, WITH 18 PARTICIPANTS PRESENTING RESEARCH POSTERS, COMPETING FOR CASH SCHOLARSHIPS. THEIR PROJECTS REFLECTED THE COMPLEXITY OF FOOD SYSTEMS AND THE VITAL CONNECTION BETWEEN NUTRITION AND HEALTH. KC ONE HEALTH DAY CONTINUES TO FOSTER COLLABORATION AND KNOWLEDGE-SHARING, REINFORCING THE IMPORTANCE OF A ONE HEALTH APPROACH. BY BRIDGING DISCIPLINES AND ENGAGING BOTH STUDENTS AND PROFESSIONALS, THE EVENT UNDERSCORES LIFE SCIENCES INITIATIVES IN THE KC REGION. 9. NEXUS INFORMATICS CONFERENCE THE NEXUS INFORMATICS CONFERENCE, POWERED BY BIONEXUS KC, CONVENED EXPERTS AND LEADERS FROM INDUSTRY, ACADEMIA, MEDICINE, AGRICULTURE, TECHNOLOGY, AND BIOLOGY. THIS TWO-DAY EVENT, HELD AT CHILDREN'S MERCY RESEARCH INSTITUTE, SERVED AS A DYNAMIC PLATFORM FOR KNOWLEDGE EXCHANGE, SHOWCASING THE LATEST ADVANCEMENTS IN INFORMATICS AND FOSTERING COLLABORATION AMONG DIVERSE DISCIPLINES. THE CONFERENCE FEATURED TWO KEYNOTE SPEAKERS WHO EXPLORED THE EVOLVING ROLE OF INFORMATICS. HARRY CAUFIELD, PHD, FROM LAWRENCE BERKELEY NATIONAL LABORATORY PRESENTED ON INTEGRATING ARTIFICIAL INTELLIGENCE WITH BIOMEDICAL DATA TO DRIVE DISCOVERY. MAIA HIGHTOWER, MD, FOUNDER OF EQUALITY AI, EMPHASIZED THE NEED FOR ETHICAL AND EQUITABLE ARTIFICIAL INTELLIGENCE APPLICATIONS IN MEDICAL DECISION-MAKING. THE CONFERENCE COVERED MANY DIVERSE TOPICS: ENVIRONMENTAL DATA, FOOD SYSTEMS, ADVANCED IMAGE ANALYSIS, REAL-WORLD PUBLIC HEALTH APPLICATIONS, AND DISEASE PREVENTION INFORMATICS. EACH SESSION FEATURED A PANEL DISCUSSION, ALLOWING ATTENDEES TO ASK QUESTIONS, AND GAIN DEEPER INSIGHTS INTO THE LATEST ADVANCEMENTS. INDUSTRY LEADERS ALSO SHARED REAL-WORLD EXAMPLES OF INFORMATICS, DEMONSTRATING HOW DATA IS TRANSFORMING HEALTHCARE AND LIFE SCIENCES. |
| FORM 990, PART VI, SECTION B, LINE 11B | FORM 990 IS REVIEWED BY THE AUDIT COMMITTEE. THE FULL BOARD OF DIRECTORS RECEIVES A COPY OF THE FORM PRIOR TO FILING WITH THE IRS. |
| FORM 990, PART VI, SECTION B, LINE 12C | ALL STAFF AND DIRECTORS MUST SUBMIT ANY CONFLICTS OF INTEREST ON AN ANNUAL BASIS. IF A CONFLICT ARISES WITHIN THE BOARD, THE DISCLOSING INDIVIDUAL SHALL NEITHER VOTE NOR ENDEAVOR TO INFLUENCE THE DECISION. |
| FORM 990, PART VI, SECTION B, LINE 15A | COMPENSATION OF THE ORGANIZATION'S PRESIDENT & CEO IS AGREED UPON BY THE BOARD OF DIRECTORS AND FINALIZED VIA A WRITTEN EMPLOYMENT CONTRACT. THIS APPROVAL IS DOCUMENTED IN THE MINUTES OF THE BOARD. THE ORGANIZATION USES A COMPENSATION COMMITTEE AND CONDUCTS A COMPENSATION STUDY TO FACILITATE THE COMPENSATION PROCESS. |
| FORM 990, PART VI, SECTION C, LINE 19 | THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE ONLY AVAILABLE UPON REQUEST. |
| FORM 990, PART IX, LINE 11G | CONSULTANTS: PROGRAM SERVICE EXPENSES 185,596. MANAGEMENT AND GENERAL EXPENSES 11,915. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 197,511. PAYROLL PROCESSING FEES: PROGRAM SERVICE EXPENSES 45,209. MANAGEMENT AND GENERAL EXPENSES 18,312. FUNDRAISING EXPENSES 1,509. TOTAL EXPENSES 65,030. CENSUS: PROGRAM SERVICE EXPENSES 18,000. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 18,000. BIOHUB MANAGEMENT: PROGRAM SERVICE EXPENSES 199,570. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 199,570. |
| FORM 990, PART XI, LINE 9: | RECOVERY OF PRIOR YEAR GRANTS 40,000. |
| FORM 990, PART XII, LINE 1: | THE ORGANIZATION'S FINANCIAL STATEMENTS HAVE BEEN PREPARED ON THE MODIFIED CASH BASIS OF ACCOUNTING, WHICH IS A BASIS OF ACCOUNTING OTHER THAN ACCOUNTING PRINCIPLES GENERALLY ACCEPTED IN THE UNITED STATES OF AMERICA. UNDER THIS METHOD OF ACCOUNTING, PROPERTY AND EQUIPMENT IS CAPITALIZED AS AN ASSET ON THE STATEMENTS OF ASSETS AND NET ASSETS - MODIFIED CASH BASIS, AND DEPRECIATION EXPENSE AND GAINS AND LOSSES ON DISPOSAL OF PROPERTY AND EQUIPMENT ARE RECORDED ON THE STATEMENTS OF REVENUES, EXPENSES AND CHANGES IN NET ASSETS - MODIFIED CASH BASIS. ADDITIONALLY, INVESTMENTS ARE RECORDED AS AN ASSET ON THE STATEMENTS OF ASSETS AND NET ASSETS - MODIFIED CASH BASIS, AND GAINS AND LOSSES RELATED TO THE INVESTMENTS ARE RECORDED ON THE STATEMENTS OF REVENUES, EXPENSES AND CHANGES IN NET ASSETS - MODIFIED CASH BASIS. ALL OTHER ELEMENTS OF THE FINANCIAL STATEMENTS ARE MAINTAINED ON THE CASH BASIS OF ACCOUNTING. |
| FORM 990, PART XII, LINE 2C: | THE ORGANIZATION HAS AN AUDIT COMMITTEE THAT ASSUMES RESPONSIBILITY FOR OVERSIGHT OF THE AUDIT OF ITS FINANCIAL STATEMENTS AND SELECTION OF AN INDEPENDENT ACCOUNTANT. THIS PROCESS HAS NOT CHANGED FROM PRIOR YEARS. |
| Software ID: | |
| Software Version: |